Advertisement

AIDS in Asia pp 561-569 | Cite as

Japan’s Collaboration with Thailand in the Development of an HIV/AIDS Vaccine

  • Kazuhiro Matsuo
  • Pilaipan Puthavathana
  • Duanthanorm Promkhatkaew
  • Kruavon Balachandra
  • Kiat Ruxrungtham
  • Takaichi Hamano
  • Ruengpung Sutthent
  • Nopporn Sittisombut
  • Raywadee Butraporn
  • Bussarawan Sriwanthana
  • Jotika Boonlong
  • Yasuyuki Izumi
  • Shudo Yamazaki
  • Naoki Yamamoto
  • Paijit Warachit
  • Mitsuo Honda

Abstract

On March 26, 1998, the Japan Science and Technology Corporation, Japan’s Ministry of Education, Science and Culture, Ministry of Health, Labor and Welfare, and Thailand’s Department of Medical Sciences and Ministry of Public Health jointly launched a bilateral collaborative HIV vaccine project with equal partnership. This international collaboration primarily focused on in-country capacity building for HIV vaccine research and development, and preclinical development of the Thailand-Japan AIDS vaccine candidates that targeted the prevalent HIV-1 subtype in Thailand—HIV CRFO1 AE—with potential for work with other types of vaccines as well in Thailand.

Keywords

Human Immunodeficiency Virus Type Mycobacterium Bovis Smallpox Vaccine Detectable Adverse Effect Challenging Shiv 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albright, A.V., Shieh, J.T., Itoh, T., Lee, B., Pleasure, D., O’Connor, M.J., Doms, R.W., and GonzalezScarano, F. (1999). Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73: 205–213.PubMedGoogle Scholar
  2. Ananworanich, J., Nuesch, R., Teeratakulpisarn, S., Srasuebkul, P., Chuenyam, T., Siangphoe, U., Ungsedhaphand, C., Phanuphak, P., and Ruxrungtham, K. (2003). In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy. JAcquir Immun Defic Syndr 32: 570–572.CrossRefGoogle Scholar
  3. Ariyoshi, K., Promadej, N., Ruxrungtham, K., and Sutthent, R. (2002). Toward improved evaluation of cytotoxic T-lymphocyte (CTL)-inducing HIV vaccines in Thailand. AIDS Res. Hum. Retroviruses 18: 737–739.PubMedCrossRefGoogle Scholar
  4. Balachandra, K., Matsuo, K., Sutthent, R., Hoisanka, N., Boonsarthorn, N., Sawanpanyalert, P., Warachit, P., Yamazaki, S., and Honda, M. (2002). Characteristic of HIV-1 in V3 loop region based on seroreactivity and amino acid sequences in Thailand. Asian Pac J Allergy Immunol 20: 93–98.PubMedGoogle Scholar
  5. Carroll, M.W. and Moss, B. (1997). Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238: 198–211.PubMedCrossRefGoogle Scholar
  6. Chujoh, Y., Matsuo, K., Yoshizaki, H., Nakasatomi, T., Someya, K., Okamoto, Y., Naganawa, S., Haga, S., Yoshikura, H., Yamazaki, A., Yamazaki, S., and Honda, M. (2002). Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B’ strains by recombinant Mycobacterium bovis BCG-based candidate vaccine. Vaccine 20: 797–804.CrossRefGoogle Scholar
  7. Fujii, R., and Minamitani, M. (1968). Virus infections with exanthema. Saishin Igaku 23:1146–1155. In Japanese.Google Scholar
  8. Fukada, K., Tomiyama, H., Wasi, C., Matsuda, T., Kusagawa, S., Sato, H., Oka, S., Takebe, Y., and Takiguchi, M. (2002). Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients. AIDS 16: 701–711.Google Scholar
  9. Hamano, T., Sawanpanyalert, P., Yanai, H., Piyaworawong, S., Hara, T., Sapsutthipas, S., Phromjai, J., Yamazaki, S., Yamamoto, N., Warachit, E, Honda, M., and Matsuo, K. (2004). Determination of HIV-1 CRFO1AE gag p17 and env-V3 consensus sequences for HIV/AIDS vaccine design. AIDS Res Hum Retroviruses (in press)Google Scholar
  10. Ishii, K., Ueda, Y., Matsuo, K., Matsuura, Y., Kitamura, T., Kato, K., Izumi, Y., Someya, K., Ohsu, T., Honda, M., and Miyamura, T. (2002). Structural analysis and application of vaccinia virus DIs strain as a completely replication-deficient viral vector for HIV vaccine. Virology 302: 433–444.PubMedCrossRefGoogle Scholar
  11. Izumi, Y., Ami, Y., Matsuo, K., Someya, K., Sata, T., Yamamoto, N., and Honda, M. (2003). Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic 568 JAPAN’S COLLABORATION WITH THAILAND IN THE DEVELOPMENT OF AN HIV/AIDS VACCINE simian-human immunodeficiency virus in monkeys. J Virol 77: 13248–13256.PubMedCrossRefGoogle Scholar
  12. Kanekiyo, M., Matsuo, K., Hamatake, M., Yamamoto, N., Honda, M. (2003). Optimization of codon usage confers vigorous expression in recombinant Mycobacterium bovis BCG vaccine. Proceedings of the International Symposium on Research and Development of Recombinant BCG and Vaccinia Virus-based HIV Vaccine. Tokyo, Japan; 21–24.Google Scholar
  13. Kawahara, M., Hashimoto, A., Toida, I., and Honda, M. (2002). Oral recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity. Clin Immunol 105: 326–331.PubMedCrossRefGoogle Scholar
  14. Kitamura, T., Kitamura, Y., and Tagaya, I. (1967). Immunogenicity of an attenuated strain of vaccinia virus on rabbits and monkeys. Nature 215: 1187–1188.PubMedCrossRefGoogle Scholar
  15. Kitsutani, P. T., Naganawa, S., Shiino, T., Matsuda, M., Honda, M., Yamada, K., Taki, M., and Sugiura, W. (1998). HIV type 1 subtypes of nonhemophiliac patients in Japan. AIDS Res Hum Retroviruses 14: 1099–1103.PubMedCrossRefGoogle Scholar
  16. Kusagawa, S., Sato, H., Tornita, Y., Tatsumi, M., Kato, K., Motomura, K., Yang, R., and Takebe, Y. (2002). Isolation and characterization of replication-competent molecular DNA clones of HIV type 1 CRFOLAE with different coreceptor usages. AIDS Res Hum Retroviruses 18: 115–122.PubMedCrossRefGoogle Scholar
  17. Lagranderie, M., Balazuc, A.M., Gicquel, B., and Gheorghiu, M. (1997). Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice. J Virol 71: 2303–2309.PubMedGoogle Scholar
  18. Matsuo, K., Nakasone, T., Izumi, Y., Ami, Y., Ohsu, T., Hamano, T., Yamamoto, N., Yamazaki, S., and Honda, M. (2002). SIV Gag-expressing recombinant BCG-prime and recombinant vaccinia virus DIs strain-boost regimen evokes protective immune response in monkey. XIV International AIDS Conference; July 2002. Barcelona, Spain. TuOrA 1222.Google Scholar
  19. Nabel, G.J. (2001). Challenges and opportunities for development of an AIDS vaccine. Nature 410: 1002–1007.PubMedCrossRefGoogle Scholar
  20. Naganawa, S., Na Ayuttaya, P.I., Duangchanda, S., Auwanit, W., Warachit, P., Miyamura, K., Yamazaki, S., and Honda, M. (1997). A characteristic change of consensus core motif in the V3 region of HIV type 1 clade B, but not in clade E, in Thailand. AIDS Res Hum Retroviruses 13: 271–273.Google Scholar
  21. Ogura, A., Noguchi, Y., Yamamoto, Y., Shibata, S., Asano, T., Okamoto, Y., and Honda, M. (1996). Localization of HIV-1 in human thymic implant in SCID-hu mice after intravenous inoculation. Int J Exp Pathol 77: 201–206.PubMedCrossRefGoogle Scholar
  22. Okamoto, Y., Ogura, A., Shibata, S., Amagai, T., Katsura, Y., Asano, T., and Honda, M. (1997). Simple i.v. inoculation of HIV-1 to Thy/Liv SCID-hu mice induce reproducible HIV infection with narrowing of medulla in human thymic implant. J Vet Med Sci. 59: 259–263.PubMedCrossRefGoogle Scholar
  23. Okamoto, Y., Eda, Y., Ogura, A., Shibata, S., Amagai, T., Katsura, Y., Asano, T., Kimachi, K., Makizumi, K., and Honda, M. (1998). In SCID-hu mice, passive transfer of a humanized antibody prevents infection and atrophic change of medulla in human thymic implant due to intravenous inoculation of primary HIV-1 isolate. J Immunol 160: 69–76.PubMedGoogle Scholar
  24. Ruxrungtham, K., and Phanuphak, P. (2001). Update on HIV/AIDS in Thailand. JMedAssoc Thai 84 Suppl 1: S1 - S17.Google Scholar
  25. Ruxrungtham, K., Buranapraditkul, S., Kosonsiriluk, S., Kerdsanti, S., Hansasutha, P., Sirivichaykul, S., Rowland-Jones, S., and Phanuphak, P. (2003). HIV-1 specific cytotoxic T-lymphocytes (CTLs) study. Proceedings of the International Symposium on Research and Development of Recombinant BCG and Vaccinia Virus-based HIV Vaccine. Tokyo, Japan; 43–52.Google Scholar
  26. Sakai, K., Shinohara, K., Takahashi, E., Izumi, Y., Ami, Y., Sasaki, Y., Nakasone, T., and Honda, M. (2001). Molecular cloning of a pathogenic simian-human immunodeficiency virus for HIV/AIDS monkey model. Sixth International Congress on AIDS in Asia and the Pacific; 2001 Oct 5–10. Melbourne, Australia. Abstract p. 84. Proc Int Cong AIDS Asia Pacific 6: 84.Google Scholar
  27. Schultz, A.M., and Bradac, J.A. (2001). The HIV vaccine pipeline, from preclinical to phase III. AIDS 15: 8147–8158.Google Scholar
  28. Shinohara, K., Sakai, K., Ando, S., Ami, Y., Yoshino, N., Takahashi, E., Someya, K., Suzaki, Y., Nakasone, T., Sasaki, Y., Kaizu, M., Lu, Y., and Honda, M. (1999). A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey. J Gen Virol 80: 1231–1240.PubMedGoogle Scholar
  29. Sutthent, R., Sumrangsurp, K., Wirachsilp, P., Chaisilwattana, P., Roongpisuthipong, A., Chaiyakul, P., Nooma, P, Honda, M., and Warachit, P. (2001). Diversity of HIV-1 subtype E in semen and cervicovaginal secretion. J Hum Virol 4: 260–268.Google Scholar
  30. Tagaya, I., Kitamura, T., and Sano, Y. (1961). A new mutant of dermovaccinia virus. Nature 192: 381–382.PubMedCrossRefGoogle Scholar
  31. Vejbaesya, S., Eiermann, T.H., Suthipinititharm, P., Bancha, C., Stephens, H.A., Luangtrakool, K., and Chandanayingyong, D. (1998). Serological and molecular analysis of HLA class I and II alleles in Thai patients with psoriasis vulgaris. Tissue Antigens 52: 389–392.PubMedCrossRefGoogle Scholar
  32. Ward, F.E., Than, S., and Haynes, B.F. (1995). Analysis of HLA Frequencies in Population Cohorts for Design of HLA-Based HIV Vaccines. In: Korber, B., Brander, C., Walker, B.D., Koup, R., Moore, J.P., Haynes, B.F., and Myers, G. (eds.), HIV Molecular Immunology Database 1995, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM. pp. IV-10–16.Google Scholar
  33. Weniger, B.G., Takebe, Y., Ou, C.Y., and Yamazaki, S. (1994). The molecular epidemiology of HIV in Asia. AIDS 8 Suppl 2: S13 — S28.Google Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Kazuhiro Matsuo
    • 1
  • Pilaipan Puthavathana
    • 2
  • Duanthanorm Promkhatkaew
    • 3
  • Kruavon Balachandra
    • 3
  • Kiat Ruxrungtham
    • 4
  • Takaichi Hamano
    • 1
  • Ruengpung Sutthent
    • 2
  • Nopporn Sittisombut
    • 5
  • Raywadee Butraporn
    • 3
  • Bussarawan Sriwanthana
    • 3
  • Jotika Boonlong
    • 3
  • Yasuyuki Izumi
    • 1
  • Shudo Yamazaki
    • 1
  • Naoki Yamamoto
    • 1
  • Paijit Warachit
    • 6
  • Mitsuo Honda
    • 1
  1. 1.AIDS Research CenterNational Institute of Infectious DiseasesTokyoJapan
  2. 2.Siriraj HospitalMahidol UniversityBangkokThailand
  3. 3.Department of Medical SciencesMinistry of Public HealthNonthaburiThailand
  4. 4.Chulalongkorn UniversityBangkokThailand
  5. 5.Chiang Mai UniversityChiang MaiThailand
  6. 6.Ministry of Public HealthNonthaburiThailand

Personalised recommendations